Log In
BCIQ
Print this Print this
 

VRP700

  Manage Alerts
Collapse Summary General Information
Company Verona Pharma plc
DescriptionAnti-tussive compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCough
Indication DetailsTreat chronic severe cough
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today